– Corrona acquires patient experience company HealthiVibe to further expand its presence in the patient experience marketplace.
– HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives at every stage of the product lifecycle.
Corrona, LLC, a provider of real-world observational and syndicated registry data, announced today that it has acquired HealthiVibe, LLC, an Arlington, VA-based patient experience company. Financial details of the acquisition were not disclosed.
Founded in 2014, HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives at every stage of the product lifecycle. The company leverages innovative, co-creation models and global online analytic platforms to provide clients with the tools and the expertise to gather, analyze and apply deep patient insights to optimize clinical trials and enhance overall product commercialization efforts.
Acquisition Benefits for Corrona
Corrona provides real-world evidence through syndicated registry data and analysis services, helping biopharmaceutical companies demonstrate the value of their products to clinicians, patients, payers, and regulators. The acquisition of HealthiVibe complements and strengthens Corrona’s strong presence in disease registries by providing market-leading expertise in supporting innovative, evidence-based patient engagement initiatives across the product lifecycle.
With projects in over 60 countries and more than 90 indications, HealthiVibe also brings valuable global experience and breadth to Corrona. Corrona operates six major autoimmune registries across the US, Canada, and Japan, collecting data from over 500 participating investigator sites.
“We believe this is a perfect fit for both HealthiVibe and Corrona,” said Abbe Steel, CEO of HealthiVibe. “In response to the FDA’s Patient-Focused Drug Development Initiative and the 21st Century Cures Act, pharmaceutical companies are investing time and energy in patient insights and real-world evidence. Marrying those two by linking together HealthiVibe’s patient insight background with Corrona’s industry-leading real-world evidence data, and drawing on Corrona’s deep relationships with sites and patients will bring significant value to our clients.”
In addition to her title of CEO of HealthiVibe, Abbe will also be taking on the newly created role of Chief Patient Officer at Corrona.
